您好,欢迎访问三七文档
,[1]..,2001:6042606.[2]..,2006,28(4):17218.[3],,..,2006,39:117.672,,3/d;,3/d,197130%70100%;75168%53133%,2=41420(P0105);2=71768(P0101),,;;;ToevaluatethefusidicacidintreatmentofcrustedtetterGUOWen2li,LIKe2han,YANGYu2hui.Depart2mentofDermatology,StaffHospitalofLouyangBearingCorporation,Luoyang,HenanProvince471003,ChinaAbstractObjectiveToevaluateclinicalefficacyandsafetyoffusidicacidintreatmentofcrustedtetter.MethodsNinty2sixcaseswererandomlydividedintotreatmentgroup(52cases)andcontrolgroup(44cases).Treatmentgroupwasgivenfusidicacidcreamtopicalapplication,tid.Controlgroupwasgivenerythromy2cinointmenttopicalapplication,tid.Thetreatmentdurationwere7dforbothgroups.ResultsThetotaleffec2tiveratesoftreatmentgroupandcontrolgroupwere96115%,72173%,respectively(P0101).Thecureratesoftwogroupwere75100%,54155%,respectively(P0105).Therewereobviousstatisticaldifferenceamongthetotaleffectiveratesandthecurerates.Noobviousside2effectsappearedduringtheentiretrial.ConclusionFusidicacidhashigheffectiveandsafetyinthetreatmentofcrustedtetter.KeywordsFusidicacid;Crustedtetter;Efficacy;Treatment,,206070,,,,[1]2007320088,,,,167,45,22,315,,:;3d;1,;,37,(512211);30,(513212)(P0105)221167,[2]:;3d;3d;2122%(:,),3/d21311,7,,,214[3]::,100%;:,,60%100%;:,,30%60%;:30%,=+215,P01053311,11(,%)(%)3728(75168)8(21162)1(2170)036(97130)3016(53133)5(16167)5(16167)4(13133)21(70100)3122=41420,P0105;2=16,13();()313712009233ChinJModDrugAppl,Feb2009,Vol.3,No.3778P001:471004A,1962,G,,,[328]G+,,[4],Koning[9],155%,[10211],97130%70100%;75168%53133%,2=71768(P0101);2=41420(P0105),,,,,[1],..,2008,7(1):37238.[2]..,2001:98.[3].,1997.[4]ChfistiansenK.Fusidicacidnon2antibacterialactivity.IntJAntimicrobAgents,1999,12:73.[5]TumdgeJ,CollignonP.Resistancetofusidicacid.IntJAntimicrobAgents,1999,12:S35.[6]VerbistL.Theantimicrobialactivityoffusidicacid.AntimicrobChemother,1990,25(SupplB):7.[7]WilkinsonJD.Fusidicacidindermatology.BrJDermatol,1998,139(Supp153):37240.[8]CbrboneM,FeraMT,PennisiMG,etal.Activityofninefluoroguin2olonesagainststrainsofBordetellabronchiseptica.IntJAntimicrobAgents,1999,12(4):3552358.[9]KoningS,vanSuijlekom2SmitLW,NouwenJL,etal.Fusidicacidcreaminthetreatmentofimpetigoingeneralpractice:doubleblindrandomizedplacebocontrolledtrial.BMJ,2002,324:2032206.[10],,,..,2007,36(7):4662468.[11],..,2002,1(1):71274.2525,624,,,,,;;;Mesh2plugtension2freeherniarepairinincarceratedherniaYANGHao2xin.HuairouDistrictHospitalforChineseMedicine,Beijing101400,ChinaAbstractObjectiveApplicationoffillingtension2freeherniarepairforthetreatmentofincarceratedinguinalhernia.MethodsFilledwithtension2freeherniarepairforthetreatmentof25casesofincarceratedherniabyBardmeshperbixplug.Theageof25caseswerebetweentheagesof4280.ResultsThe25pa2tientswerecured.Follow2upof624months,norelapsecases.ConclusionFilledwithtension2freeherniare2pairforthetreatmentofincarceratedinguinalherniawasappropriate.Andthiswouldshortentheoperationtime.Theoperationhasachievedgoodresults,reducedpatientspaindandrecurrence.KeywordsIncarceratedhernia;Groin;Tension2free;Plugmeshherniarepair,[122],,200222007(Bardmeshperbixplug)2515,5,320,11,5636h,8h,16,3,1,1B,(Bx),,[3]812009233ChinJModDrugAppl,Feb2009,Vol.3,No.3:10140011124280212ardardmeshperbiplug
本文标题:中国现代药物应用
链接地址:https://www.777doc.com/doc-348489 .html